Atrophy, Fibrosis, and Increased PAX7-Positive Cells in Pharyngeal Muscles of Oculopharyngeal Muscular Dystrophy Patients
about
204th ENMC International Workshop on Biomarkers in Duchenne Muscular Dystrophy 24-26 January 2014, Naarden, The NetherlandsHuman skeletal muscle-derived CD133(+) cells form functional satellite cells after intramuscular transplantation in immunodeficient host miceThe EuroBioBank Network: 10 years of hands-on experience of collaborative, transnational biobanking for rare diseasesAltered cross-bridge properties in skeletal muscle dystrophiesMitochondrial dysfunction reveals the role of mRNA poly(A) tail regulation in oculopharyngeal muscular dystrophy pathogenesisPatterns of Age-Associated Degeneration Differ in Shoulder MusclesPharyngeal Satellite Cells Undergo Myogenesis Under Basal Conditions and Are Required for Pharyngeal Muscle MaintenanceNuclear poly(A)-binding protein aggregates misplace a pre-mRNA outside of SC35 speckle causing its abnormal splicing.Correlation between PABPN1 genotype and disease severity in oculopharyngeal muscular dystrophy.PABPN1 gene therapy for oculopharyngeal muscular dystrophyPABPN1: molecular function and muscle disease.Invited review: Stem cells and muscle diseases: advances in cell therapy strategies.PABPN1 (GCN)11 as a Dominant Allele in Oculopharyngeal Muscular Dystrophy -Consequences in Clinical Diagnosis and Genetic CounsellingGlycosaminoglycan modifications in Duchenne muscular dystrophy: specific remodeling of chondroitin sulfate/dermatan sulfate.Oropharyngeal dysphagia profiles in individuals with oculopharyngeal muscular dystrophy.Muscle satellite cells are functionally impaired in myasthenia gravis: consequences on muscle regeneration.Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology.
P2860
Q28611318-3B14D9B2-91EF-48C2-8FED-EF7F4922FD36Q33562298-050B34A4-EAFB-49D2-A321-16586AAD763AQ34042850-F3629402-51BE-454F-8538-C66F66BC3F0EQ34335939-454FA790-2803-4C4A-A656-8DEA7AB9E61CQ35224241-B8D271C4-5251-444B-B76F-5A64D79DC642Q36391942-E034D335-9ACD-4FCB-9979-3C66CD2A8BF3Q36463987-30146057-CE0F-4B6D-9328-D6CBD04092BAQ37507541-8A8A3D16-C11A-4B4C-A898-2AF81CD9A57EQ37610918-ABFBA608-A54F-44C4-B25D-29C793C88F7FQ37737844-8C08F8EE-D982-4CA0-9ACC-6F648E003D26Q38100286-CE86861B-C1B6-4F0D-9A0F-825B1BA64DBFQ38269131-1EBCA8BE-8AE1-4617-B3A7-3D1DC8580B56Q41956578-E7366058-CDA4-4618-92AB-96C6AAF6B9F3Q42670912-2ED22BC5-B320-4E97-A5FC-28062B5D44E2Q48292271-9E8B8A59-3617-4191-A8DD-8FB77DCD2F69Q50516728-3C559F4E-4AE4-4869-B957-3BD008449583Q50962265-3DDEA78B-488D-4564-89DA-FC9A2195E005
P2860
Atrophy, Fibrosis, and Increased PAX7-Positive Cells in Pharyngeal Muscles of Oculopharyngeal Muscular Dystrophy Patients
description
im März 2013 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2013
@uk
name
Atrophy, Fibrosis, and Increas ...... al Muscular Dystrophy Patients
@en
Atrophy, Fibrosis, and Increas ...... al Muscular Dystrophy Patients
@nl
type
label
Atrophy, Fibrosis, and Increas ...... al Muscular Dystrophy Patients
@en
Atrophy, Fibrosis, and Increas ...... al Muscular Dystrophy Patients
@nl
prefLabel
Atrophy, Fibrosis, and Increas ...... al Muscular Dystrophy Patients
@en
Atrophy, Fibrosis, and Increas ...... al Muscular Dystrophy Patients
@nl
P2093
P2860
P50
P1476
Atrophy, Fibrosis, and Increas ...... al Muscular Dystrophy Patients
@en
P2093
Jean Lacau St Guily
Jeanne Lainé
Teresa Gidaro
P2860
P304
P356
10.1097/NEN.0B013E3182854C07
P50
P577
2013-03-01T00:00:00Z